Skip to main content
. 2019 Jul-Sep;11(3):232–239. doi: 10.4103/jpbs.JPBS_82_19

Table 1.

Comparison of demographic and clinical characteristics between patients with controlled versus uncontrolled blood pressure

Characteristics Total Uncontrolled Controlled P value
n= 300 (%) n = 184 (%) n = 116 (%)
Sex 0.006
 Female 202 (67.3) 113 (61.4) 89 (76.7)
 Male 98 (32.7) 71 (38.6) 27 (23.3)
Age <60 years 173 (57.7) 116 (63.0) 57 (49.1) 0.015
Age ≥60 years 127 (42.3) 68 (37.0) 59 (50.9)
BMIa 31.7 (6.5) 32.4 (5.5) 31.8 (5.3) 0.428
Smoking status 0.966
 Smoker 27 (9.0) 16 (8.7) 11 (9.5)
 Ex-smoker 51 (17.0) 31 (16.8) 20 (17.2)
 Nonsmoker 222 (74.0) 137 (74.5) 85 (73.3)
Education 0.785
 Primary/no formal education 174 (58.0) 104 (56.5) 70 (60.3)
 Middle/secondary school 40 (13.3) 26 (14.1) 14 (12.1)
 Postsecondary 86 (28.7) 54 (29.3) 32 (27.6)
Employment status
 Employed 52 (17.3) 32 (17.4) 20 (17.2) 0.973
 Retired 50 (16.7) 33 (17.9) 17 (14.7) 0.458
Hypertension duration (SD), years 8.9 (7.7) 8.9 (8.0) 8.8 (7.3) 0.849
Medical history
 Stroke 14 (4.7) 10 (5.4) 4 (3.4) 0.427
 Acute coronary syndrome 18 (6.0) 8 (4.3) 10 (8.6) 0.129
 Ischemic heart disease 44 (14.7) 25 (13.6) 19 (16.4) 0.506
 Diabetes mellitus 105 (35) 84 (45.7) 21 (18.1) <0.001
 Diabetes duration (SD), years 7.9 (6.4) 8.2 (6.6) 6.9 (5.3) 0.340
 Dyslipidemia 173 (57.7) 102 (55.4) 71 (61.2) 0.324
 CKD 6 (2.0) 6 (3.3) 0 (0.0) 0.085
 Rheumatoid arthritis 14 (4.7) 8 (4.3) 6 (5.2) 0.742
 Thyroid diseases 14 (4.7) 7 (3.8) 7 (6.0) 0.372
Number of hypertension medications 0.456
 1 159 (53.0) 102 (55.4) 57 (49.1)
 2 116 (38.7) 66 (35.9) 50 (43.1)
 3 25 (8.3) 16 (8.7) 9 (7.8)
Fixed-dose combination 78 (26.0) 48 (26.1) 30 (25.9) 0.966
Hypertension medication
 ACEI/ARB 224 (74.7) 138 (75.0) 86 (74.1) 0.867
 Beta-blocker 88 (29.3) 53 (28.8) 35 (30.2) 0.800
 Calcium channel blocker 84 (28.0) 51 (27.7) 33 (28.4) 0.891
 Diuretic 69 (23.0) 39 (21.2) 30 (25.9) 0.350

SD = standard deviation

aBMI available for 223/300 patients (73.7%)